Trials / Completed

CompletedNCT00549289

Study of Cyclosporine in the Treatment of Dry Eye Syndrome (ST-603-006)

Status: Completed
Phase: Phase 3
Study type: Interventional
Enrollment: —

Sponsor: Sirion Therapeutics, Inc. · Industry
Sex: All
Age: 2 Years
Healthy volunteers: —

Summary

The purpose of this phase III, open-label study is to determine the safety and tolerability of cyclosporine in the treatment of dry eye syndrome.

Conditions

Dry Eye Syndromes

Interventions

Type	Name	Description
DRUG	cyclosporine A

Timeline

First posted: 2007-10-25
Last updated: 2007-10-25

Locations

1 site across 1 country: United States

Source: ClinicalTrials.gov record NCT00549289. Inclusion in this directory is not an endorsement.